MedTrace Logo

Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood

NCT00550667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1120

Last updated 2021-09-02

No results posted yet for this study

Summary

This study aims to establish the psychometric properties of the Adult ADHD Quality of Life Scale (AAQoL) and to validate the diagnosis of adult ADHD by ADHD symptoms, other clinical psychiatric symptoms, neuropsychological functioning, social/family/occupational functioning, and intervention effect.

Conditions

  • Attention Deficit Disorder With Hyperactivity

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Susan Shur-Fen Gau, MD, PhD · Dept of Psychiatry, National Taiwan University Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-01
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00550667 on ClinicalTrials.gov